Primary Site >> Colorectal Cancer

Gene >> HAVCR2

  • 2012
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T Cells Associated with Dysfunction of Cell-Mediated Immunity after Colorectal Cancer Operation.
PMID: 24031134
Ref: Tim-3 expression defines regulatory T cells in human tumors.
PMID: 23526963
Ref: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
PMID: 25363763
Ref: An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.
PMID: 25949894
Ref: Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.
PMID: 26008981
Ref: Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
PMID: 26339368
Ref: Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer.
PMID: 26493689
Ref: Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.
PMID: 26683225
Ref: Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
PMID: 27070448
Ref: Immunotherapy of Colorectal Cancer.
PMID: 27259331
Ref: Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.
PMID: 27757304
Ref: Down-regulated expression of Tim-3 promotes invasion and metastasis of colorectal cancer cells.
PMID: 27881010
Ref: Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression.
PMID: 28035413
Ref: Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients.
PMID: 28038383
Ref: Preoperative Tim3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
PMID: 28440449
Ref: Early and Partial Reduction in CD4(+)Foxp3(+) Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4(+) and CD8(+) T Cell Activation Inhibiting Tumorigenesis.
PMID: 29344269
Ref: CD8(+)CXCR5(+) T cells in tumor-draining lymph nodes are highly activated and predict better prognosis in colorectal cancer.
PMID: 29544815
Ref: Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
PMID: 29770915
Ref: Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.
PMID: 29900067
Ref: Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
PMID: 29905955
Ref: Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.
PMID: 29963183
Ref: DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer.
PMID: 30081950
Ref: Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer.
PMID: 30271205